Free Trial

Vontobel Holding Ltd. Has $38.90 Million Holdings in Colgate-Palmolive Company $CL

Colgate-Palmolive logo with Consumer Staples background

Vontobel Holding Ltd. lowered its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 17.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 427,903 shares of the company's stock after selling 89,176 shares during the period. Vontobel Holding Ltd. owned approximately 0.05% of Colgate-Palmolive worth $38,896,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Personal CFO Solutions LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter worth about $285,000. Vision Capital Management Inc. bought a new position in shares of Colgate-Palmolive in the first quarter worth about $322,000. Autumn Glory Partners LLC increased its stake in shares of Colgate-Palmolive by 67.4% in the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after purchasing an additional 3,586 shares during the period. Financial Gravity Asset Management Inc. bought a new position in shares of Colgate-Palmolive in the first quarter worth about $2,166,000. Finally, Penserra Capital Management LLC increased its stake in shares of Colgate-Palmolive by 398.6% in the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after purchasing an additional 8,515 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on CL shares. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating on the stock in a research note on Thursday, September 25th. Piper Sandler started coverage on Colgate-Palmolive in a research note on Friday, October 3rd. They issued a "neutral" rating and a $84.00 price objective on the stock. The Goldman Sachs Group dropped their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a "buy" rating on the stock in a research note on Thursday, October 2nd. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, Morgan Stanley lowered their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and a consensus price target of $93.23.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Trading Down 1.5%

Shares of CL opened at $77.96 on Thursday. Colgate-Palmolive Company has a 12-month low of $77.09 and a 12-month high of $102.61. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The firm has a market capitalization of $63.01 billion, a price-to-earnings ratio of 21.90, a P/E/G ratio of 4.11 and a beta of 0.34. The stock's 50-day moving average price is $82.79 and its 200 day moving average price is $88.08.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same period in the previous year, the company posted $0.91 earnings per share. The company's quarterly revenue was up 1.0% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive's dividend payout ratio is currently 58.43%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.